Saturna Capital »

GSK shares owned by Saturna Capital

Quarter-by-quarter ownership of GSK (GSK) shares owned by Saturna Capital from 13F filings

Historical chart of Saturna Capital investment in GSK

Tip: Access up to 7 years of quarterly data

All positions including GSK held by Saturna Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GSK by Saturna Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 29k 37.06
2023-09-30 $956k 26k 36.25
2023-06-30 $984k 28k 35.64
2023-03-31 $923k 26k 35.58
2022-12-31 $912k 26k 35.14
2022-09-30 $5.8M 197k 29.43

More positions owned by Saturna Capital

Apple Common Stock (AAPL)
Eli Lilly Common Stock (LLY)
Microsoft Common Stock (MSFT)
ASML Holding NY Common Stock (ASML)
Taiwan Semiconductor ADS Adr (TSM)
Novo Nordisk ADS Adr (NVO)
Adobe Common Stock (ADBE)
Alphabet, Class A Common Stock (GOOGL)
Intuit Common Stock (INTU)
Advanced Micro Devices Common Stock (AMD)
Amgen Common Stock (AMGN)
Johnson Controls International Common Stock (JCI)
Cisco Systems Common Stock (CSCO)
Agilent Technologies Common Stock (A)
Broadcom Common Stock (AVGO)

View all positions for Saturna Capital

Top funds holding GSK

Dodge & Cox
JTC Employer Solutions Trustee
Fisher Investments
T. Rowe Price Associates
PRIMECAP Management Company
Royal Bank of Canada
Holocene Advisors
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership
Provident Trust
Equity Investment Corp Acquisition
Hotchkis and Wiley Capital Management
Wells Fargo & Company
Hsbc Holdings
Douglas Lane & Associates

View all funds holding GSK